Patent Assignment
Reel/Frame 014022/0197
Merger
Recorded: 2003-05-05
Pages: 11
Assignor
GELTEX PHARMACEUTICALS, INC.
Executed: 2003-03-27
Assignee
GENZYME CORPORATION
ONE KENDALL SQUARE, CAMBRIDGE, MASSACHUSETTS, 02139
Covered Properties
(85)
Iron-Binding Polymers for Oral Administration
Patent:
5,487,888 →
Application:
08/065,546 →
Phosphate-Binding Polymers for Oral Administration
Patent:
5,496,545 →
Application:
08/238,458 →
Process for Removing Bile Salts from a Patient and Compositions Therefor
Patent:
5,624,963 →
Application:
08/258,477 →
A Method for Removing Bile Salts from a Patient with Alklated Amine Polymers
Patent:
5,679,717 →
Application:
08/460,980 →
Alkylated Amine Polymers
Patent:
5,693,675 →
Application:
08/461,298 →
Hydrophobic Amine Polymer Sequestrant and Method of Cholesterol Depletion
Patent:
5,618,530 →
Application:
08/469,659 →
Phosphate-Binding Polymers for Oral Administration
Patent:
5,667,775 →
Application:
08/471,747 →
Amine Polymer Sequestrant and Method of Cholesterol Depletion
Patent:
5,607,669 →
Application:
08/471,769 →
Process for Removing Bile Salts from a Patient and Compositions Therefor
Patent:
5,703,188 →
Application:
08/482,969 →
Iron-Binding Polymers for Oral Administration
Patent:
5,702,696 →
Application:
08/567,933 →
Hydrophobic Sequestrant for Cholesterol Depletion
Patent:
5,900,475 →
Application:
08/659,264 →
Ionic Polymers as Anti-Infective Agents
Patent:
6,034,129 →
Application:
08/670,764 →
Poly (Diallylamine) -Based Bile Acid Sequestrants
Patent:
6,203,785 →
Application:
08/777,408 →
Amine Polymer Sequestrant and Method of Cholesterol Depletion
Patent:
5,919,832 →
Application:
08/779,779 →
Interpenetrating Polymer Networks for Sequestration of Bile Acids
Patent:
5,925,379 →
Application:
08/826,197 →
Method of Making Phosphate-Binding Polymers for Oral Administration
Patent:
6,083,495 →
Application:
08/929,784 →
Ionic Polymers as Toxin Binding Agents
Patent:
6,007,803 →
Application:
08/934,495 →
Process for Removing Bile Salts from a Patient and Compositions Therefor
Patent:
5,840,766 →
Application:
08/959,471 →
Poly (Diallylamines)-Based Phosphate Binders
Patent:
6,726,905 →
Application:
08/964,498 →
Method for Treating Hypercholesterolemia with Unsubstituted Polydiallylamine Polymers
Patent:
6,083,497 →
Application:
08/964,536 →
Method for Reducing Oxalate
Patent:
5,985,938 →
Application:
08/964,956 →
Method for Treating Hypercholesterolemia with Polyallylamine Polymers
Patent:
6,423,754 →
Application:
08/979,096 →
Hydrophilic Nonamine-Containing and Amine-Containing Copolymers and Their Use as Bile Acid Sequestrants
Patent:
5,929,184 →
Application:
08/999,029 →
Water-Insoluble Noncrosslinked Bile Acid Sequestrants
Patent:
6,129,910 →
Application:
08/999,351 →
Process for Removing Biles Salts from a Patient and Alkylated Compositions Therefor
Patent:
5,917,007 →
Application:
09/129,286 →
Novel Polymers Containing Guanidinium Groups as Bile Acid Sequestrants
Patent:
6,294,163 →
Application:
09/165,386 →
Fat-Binding Polymers
Patent:
6,264,937 →
Application:
09/166,453 →
Lipase Inhibiting Polymers
Patent:
6,267,952 →
Application:
09/166,510 →
Hydrophobic Sequestrant for Cholesterol Depletion
Patent:
5,969,090 →
Application:
09/185,157 →
Process for Removing Bile Salts from a Patient and Compositions Therefor
Patent:
6,060,517 →
Application:
09/191,868 →
Novel Polymers Containing Spirobicyclic Ammonium Moieties as Bile Acid Sequestrants
Patent:
6,271,264 →
Application:
09/203,319 →
Lipase Inhibiting Polymers
Patent:
6,352,692 →
Application:
09/226,585 →
Poly(Diallylamine) Based Bile Acid Sequestrants
Patent:
6,610,283 →
Application:
09/286,341 →
Process for Removing Bile Salts from a Patient and Alkylated Compositions Therefor
Patent:
5,981,693 →
Application:
09/288,357 →
Polyether-Based Bile Acid Sequestrnts
Patent:
6,190,649 →
Application:
09/298,350 →
Combination Therapy for Treating Hypercholesterolemia
Patent:
6,365,186 →
Application:
09/311,103 →
Combination Therapy for Treating Hypercholestrolemia
Patent:
6,264,938 →
Application:
09/311,402 →
Fat-Binding Polymers
Patent:
6,299,868 →
Application:
09/353,329 →
Method for Reducing Oxalate
Patent:
6,177,478 →
Application:
09/359,226 →
Process for Removing Bile Salts from a Patient and Alkylated Compositions Therefor
Patent:
6,066,678 →
Application:
09/388,876 →
Ionic polymers as anti-infective agents
Method for treating hypercholesterolemia with Unsubstituted polydiallylamine polymers
Patent:
6,248,318 →
Application:
09/521,975 →
Process for removing bile salts from a patient and alkylated compositions therefor
Patent:
6,225,355 →
Application:
09/532,984 →
aNIONIC POLYMERS AS TOXIN BINDERS
Patent:
6,270,755 →
Application:
09/541,268 →
Method of Making Phosphate-Binding Polymers for Oral Administration
Patent:
6,509,013 →
Application:
09/542,329 →
Antimicrobial Compositions and Methods
Patent:
6,482,402 →
Application:
09/568,825 →
Anionic polymers as toxin binders and antibacterial agents
Patent:
6,290,946 →
Application:
09/569,276 →
Ionic polymers as toxin-binding agents
Patent:
6,290,947 →
Application:
09/597,343 →
Iron-Binding Polymers for Oral Administration
Patent:
6,605,270 →
Application:
09/655,998 →
Method for reducing oxalate
Patent:
6,281,252 →
Application:
09/668,874 →
Direct Compression Polymer Tablet Core
Patent:
6,733,780 →
Application:
09/691,429 →
Polyether-Based Bile Acid Sequestrants
Patent:
6,517,825 →
Application:
09/713,784 →
Lipase Inhibiting Polymers
Patent:
6,572,850 →
Application:
09/714,327 →
Lipase Inhibiting Polymers
Patent:
6,558,657 →
Application:
09/714,541 →
Fat-Binding Polymers
Patent:
7,048,917 →
Application:
09/721,291 →
Fat-Binding Polymers
Patent:
6,726,906 →
Application:
09/721,310 →
Anionic Polymers as Toxin Binders and Antibacterial Agents
Patent:
6,517,826 →
Application:
09/723,596 →
Process for Removing Bile Salts from a Patient and Alkylated Compositions Therefor
Anionic Polymers as Species Specific Antibacterial Agents
Direct compression polymer tablet core
Application:
09/875,275 →
Publication:
US 2002/0054903
Bismuth Compounds for the Treatment and Prevention of Mucositis
Anionic Polymers as Toxin Binders
Method for Reducing Oxalate
Anionic Polymers as Toxin Binders and Antibacterial Agent
Patent:
6,517,827 →
Application:
09/901,206 →
A Pharmaceutical Composition for Treating Hypercholesterolemia
Ionene Polymers and Their Use as Antimicrobial Agents
Ionene polymers and their use in treating mucositis
Application:
10/051,766 →
Publication:
US 2003/0021761
Ionic Polymers as Anti-Infective Agents
Low Salt Forms of Polyallylamine
Method for treating gout and binding uric acid
Application:
10/125,685 →
Publication:
US 2003/0039627
Methods of Treating Syndrome X with Aliphatic Polyamines
Method for reducing copper levels and treating copper toxicosis
Application:
10/125,702 →
Publication:
US 2002/0182168
Method for treating gout and reducing serum uric acid
Application:
10/125,793 →
Publication:
US 2002/0187120
Method for treating hypercholesterolemia with polyallylamine polymers
Application:
10/158,207 →
Publication:
US 2003/0086898
Fat-Binding Polymers
Aryl Boronate Functionalized Polymers for Treating Obesity
Aryl Boronic Acids for Treating Obesity
Process for Removing Bile Salts from a Patient and Alkylated Compositions Therefor
Anionic Polymers as Toxin Binders and Antibacterial Agents
Fat-binding polymers
Application:
10/307,151 →
Publication:
US 2003/0175236
Method of Making Phosphate-Binding Polymers for Oral Administration
Ionic Polymers as Toxin-Binding Agents
Phosphate Transport Inhibitors
Lipase Inhibiting Polymers
Ionic Polymers as Anti-Infective Agents
Related Assignments
(13)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 16, 1993
From: W.H. MANDEVILLE III ET AL.
To: GELTEX, INC.
Reel/Frame 006678/0491 →
Assignment of Assignor's Interest
Aug 30, 1994
From: HOLMES-FARLEY, STEPHEN R.; MANDEVILLE, HARRY, III; WHITESIDES, GEORGE M.
To: GELTEX INC.
Reel/Frame 007140/0809 →
Assignment of Assignor's Interest
Dec 12, 1994
From: MANDEVILLE, W. HARRY III; HOLMES-FARLEY, STEPHEN RANDALL
To: GELTEX PHARMACEUTICALS, INC.
Reel/Frame 007252/0437 →
Assignment of Assignor's Interest
Jul 17, 1996
From: MANDEVILLE, W. HARRY III; HOLMES-FARLEY, STEPHEN RANDALL; PETERSEN, JOHN S.
To: GELTEX PHARMACEUTICALS, INC.
Reel/Frame 008381/0034 →
Assignment of Assignor's Interest
Feb 18, 1997
From: HOLMES-FARLEY, STEPHEN RANDALL; DHAL, PRADEEP K.; PETERSON, JOHN S.
To: GELTEX PHARMACEUTICALS, INC.
Reel/Frame 008367/0873 →
Assignment of Assignor's Interest
Jun 23, 1997
From: MANDEVILLE, W. HARRY III.; HOLMES-FARLEY, STEPHEN RANDALL; NEENAN, THOMAS X.; WHITESIDES, GEORGE M.
To: GELTEX PHARMACEUTICALS, INC.
Reel/Frame 008575/0695 →
Assignment of Assignor's Interest
Oct 27, 1997
From: MANDEVILLE, W. HARRY, III; NEENAN, THOMAS X.
To: GELTEX PHARMACEUTICALS, INC.
Reel/Frame 008764/0775 →
Assignment of Assignor's Interest
Feb 2, 1998
From: MANDEVILLE, W. HARRY, III; HOLMES-FARLEY, STEPHEN RANDALL
To: GELTEX PHARMACEUTICALS, INC.
Reel/Frame 008958/0927 →
Assignment of Assignor's Interest
Mar 2, 1998
From: HOLMES-FARLEY, STEPHEN RANDALL; MANDEVILLE, W. HARRY III; BURKE, STEVEN K.; GOLDBERG, DENNIS I.
To: GELTEX PHARMACEUTICALS, INC.
Reel/Frame 009011/0892 →
Assignment of Assignor's Interest
Mar 12, 1998
From: HUVAL, CHAD CORI; HOLMES-FARLEY, STEPHEN RANDALL; PETERSEN, JOHN S.; DHAL, PRADEEP K.
To: GELTEX PHARMACEUTICALS, INC.
Reel/Frame 009042/0227 →
Assignment of Assignor's Interest
Mar 23, 1998
From: HOLMES-FARLEY, STEPHEN RANDALL; MANDEVILLE, W. HARRY III
To: GELTEX PHARMACEUTICALS, INC.
Reel/Frame 009051/0027 →
Assignment of Assignor's Interest
Apr 20, 1998
From: HOLMES-FARLEY, STEPHEN RANDALL; PETERSEN, JOHN S.
To: GELTEX PHARMACEUTICALS, INC.
Reel/Frame 009122/0537 →
Assignment of Assignor's Interest
Apr 20, 1998
From: HOLMES-FARLEY, STEPHEN RANDALL; MANDEVILLE, III, W. HARRY
To: GELTEX PHARMACEUTICALS, INC.
Reel/Frame 009122/0534 →